Panomics

Less than a year after Affymetrix bought eBioscience, the array vendor is finding ways to combine its background in microarray and branched-DNA genotyping and expression with eBio's flow cytometry reagents and multiplex immunoassay portfolios.

This article was originally posted on Feb. 1

Affymetrix this week reported a slight uptick in its second-quarter revenues, which increased 3 percent to $66.4 million from $64.7 million in the year-ago period, beating the average analyst estimate of $65.6 million.

This story was originally posted on Nov. 3
By Justin Petrone

NetBio has been awarded US Patent No. 8,018,593, "Integrated nucleic acid analysis."
Eugene Tan, Heung Lam, Valery Bogdanov, Gregory Kellogg, John Wright, Ulrich Thomann, and Richard Selden are named as inventors on the patent.

IP Roundup

Premium

Korea Electro Technology Research Institute of Changwon, Korea, has received US Patent No.

Acknowledging the challenges the firm faces and admitting it has been "slow to respond to technology changes" in the market, Frank Witney said the firm still has some opportunities to restore growth — if it positions its products correctly.

Movers & Shakers

Premium

Brandon Ruotolo, Frank Witney, Kevin King, Ronald DePinho, John Mendelsohn, Lynda Chin

IP Roundup

Premium

Northwestern University, Affymetrix, Centre National de la Recherche Scientifique

INSERM and Affymetrix win US patents.

Pages

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.